InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score43
United States Fiscal year ends December CIK 0001583648 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

96
Insider
Date
Role
Action
Shares
Price
Amount
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
607
$126.19
$76.60K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
1,663
$125.16
$208.15K
Kathleen Goin
21 Oct 2026
Chief Operating Officer
Sold after exercise
2,043
$123.62
$252.56K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
505
$126.55
$63.91K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
597
$125.33
$74.82K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
920
$124.37
$114.42K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
2,604
$123.29
$321.05K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
2,072
$122.62
$254.06K
George M Jenkins
14 Oct 2026
Director
Sold on a plan
476
$121.14
$57.66K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
922
$133.72
$123.29K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
579
$132.40
$76.66K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
1,035
$131.49
$136.09K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
990
$130.48
$129.18K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
1,644
$129.23
$212.45K
George M Jenkins
13 Oct 2026
Director
Sold on a plan
2,004
$128.52
$257.56K
George M Jenkins
12 Oct 2026
Director
Sold on a plan
817
$136.44
$111.48K
George M Jenkins
12 Oct 2026
Director
Sold on a plan
1,447
$135.50
$196.06K
George M Jenkins
12 Oct 2026
Director
Sold on a plan
3,335
$134.21
$447.59K
George M Jenkins
12 Oct 2026
Director
Sold on a plan
2,458
$133.25
$327.52K
George M Jenkins
12 Oct 2026
Director
Sold on a plan
5,095
$132.62
$675.68K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
1,654
$153.24
$253.46K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
989
$152.36
$150.69K
Kathleen Goin
16 Sep 2026
Chief Operating Officer
Sold after exercise
1,659
$151.16
$250.77K
George M Jenkins
15 Sep 2026
Director
Sold on a plan
560
$151.33
$84.74K
George M Jenkins
15 Sep 2026
Director
Sold on a plan
263
$150.40
$39.56K
George M Jenkins
15 Sep 2026
Director
Sold on a plan
954
$149.38
$142.51K
George M Jenkins
14 Sep 2026
Director
Sold on a plan
1,560
$153.10
$238.83K
George M Jenkins
14 Sep 2026
Director
Sold on a plan
6,160
$152.12
$937.03K
George M Jenkins
14 Sep 2026
Director
Sold on a plan
5,632
$151.46
$853.04K
George M Jenkins
11 Sep 2026
Director
Sold on a plan
1,274
$153.06
$195.00K
George M Jenkins
11 Sep 2026
Director
Sold on a plan
4,577
$151.72
$694.40K
George M Jenkins
11 Sep 2026
Director
Sold on a plan
6,520
$150.62
$982.04K
Christopher P Kiritsy
2 Sep 2026
Director
Sold after exercise
313
$157.00
$49.14K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
302
$156.77
$47.34K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
102
$155.59
$15.87K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
400
$153.00
$61.20K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
1,998
$151.80
$303.29K
Kathleen Goin
19 Aug 2026
Chief Operating Officer
Sold after exercise
1,500
$151.39
$227.09K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
1,911
$150.25
$287.13K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
1,029
$149.27
$153.60K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
840
$148.40
$124.66K
Kathleen Goin
15 Jul 2026
Chief Operating Officer
Sold after exercise
522
$147.14
$76.81K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
25
$112.23
$2.81K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
1,887
$111.31
$210.05K
Kathleen Goin
17 Jun 2026
Chief Operating Officer
Sold after exercise
2,390
$110.26
$263.52K
Matthew E Korenberg
12 Jun 2026
CFO, Treasurer
Exercised, kept
1,000
$13.60
$13.60K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
48
$111.90
$5.37K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
891
$111.30
$99.17K
Kathleen Goin
20 May 2026
Chief Operating Officer
Sold after exercise
3,363
$110.35
$371.09K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
100
$130.33
$13.03K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
639
$129.17
$82.54K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
561
$128.23
$71.94K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
1,500
$127.13
$190.69K
Kathleen Goin
15 Apr 2026
Chief Operating Officer
Sold after exercise
1,502
$125.96
$189.20K
George M Jenkins
30 Mar 2026
Director
Buy
445
$112.30
$49.97K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
304
$119.08
$36.20K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
1,730
$118.37
$204.78K
Kathleen Goin
18 Mar 2026
Chief Operating Officer
Sold after exercise
2,268
$117.56
$266.63K
Elaine J Heron
27 Feb 2026
Director
Buy
2,400
$125.00
$300.00K
George M Jenkins
27 Feb 2026
Director
Buy
4,000
$125.00
$500.00K
Kathleen Goin
18 Feb 2026
Chief Operating Officer
Sold after exercise
1,276
$79.97
$102.04K
Kathleen Goin
18 Feb 2026
Chief Operating Officer
Sold after exercise
3,026
$79.16
$239.53K
Kathleen Goin
21 Jan 2026
Chief Operating Officer
Sold after exercise
3,749
$97.94
$367.18K
Kathleen Goin
21 Jan 2026
Chief Operating Officer
Sold after exercise
553
$95.49
$52.81K
Kathleen Goin
17 Dec 2025
Chief Operating Officer
Sold after exercise
4,302
$96.47
$415.02K
Kathleen Goin
19 Nov 2025
Chief Operating Officer
Sold after exercise
2,802
$86.51
$242.39K
Kathleen Goin
19 Nov 2025
Chief Operating Officer
Sold after exercise
1,500
$85.72
$128.58K
George M Jenkins
9 Apr 2025
Director
Buy indirect
2,490
$20.27
$50.47K
George M Jenkins
9 Apr 2025
Director
Buy
2,500
$20.13
$50.33K
George M Jenkins
18 Dec 2024
Director
Buy
4,000
$12.93
$51.72K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
757
$15.88
$12.02K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
2,243
$15.88
$35.62K
ADAR1 Capital Management, LLC
9 Aug 2024
10% owner
Buy indirect
3,000
$14.89
$44.68K
James A Geraghty
7 Aug 2024
Director
Buy
1
$1.00
$1.00
Christopher P Kiritsy
25 May 2023
Director
Buy
10,000
$0.85
$8.50K
Tim Demuth
13 May 2022
Chief Medical Officer
Buy
6,000
$1.71
$10.26K
Shane Olwill
30 Aug 2021
Chief Development Officer
Sold after exercise
29,200
$5.15
$150.38K
Shane Olwill
30 Aug 2021
Chief Development Officer
Sold after exercise
9,200
$5.00
$46.00K
Aquilo Capital Management, LLC
21 Jul 2020
10% owner
Sell indirect
1,900,000
$2.95
$5.61M
Bvf Partners L P/Il
6 Sep 2019
10% owner
Sell
1,128
$4.50
$5.08K
Bvf Partners L P/Il
6 Sep 2019
10% owner
Sell
25,720
$4.50
$115.72K
Bvf Partners L P/Il
6 Sep 2019
10% owner
Sell
23,152
$4.50
$104.17K
Christopher P Kiritsy
14 Sep 2018
Director
Buy
5,000
$5.11
$25.53K
James A Geraghty
15 May 2018
Director
Buy
10,000
$5.75
$57.50K
Orbimed Advisors LLC
30 Apr 2018
10% owner
Sell indirect
10,400
$6.35
$66.04K
Orbimed Advisors LLC
30 Apr 2018
10% owner
Sell indirect
989,600
$6.35
$6.28M
Orbimed Advisors LLC
13 Feb 2018
10% owner
Sold after exercise indirect
75
$8.98
$673.50
Orbimed Advisors LLC
13 Feb 2018
10% owner
Sold after exercise indirect
7,822
$8.98
$70.24K
Orbimed Advisors LLC
3 Jan 2018
10% owner
Sell indirect
16,128
$7.35
$118.54K
Orbimed Advisors LLC
3 Jan 2018
10% owner
Sell indirect
1,693,492
$7.35
$12.45M
Orbimed Advisors LLC
18 Dec 2017
10% owner
Sold after exercise indirect
1,392
$5.70
$7.93K
Orbimed Advisors LLC
18 Dec 2017
10% owner
Sold after exercise indirect
146,243
$5.70
$833.59K
Allan Reine
17 Aug 2017
See Remarks
Buy
20,000
$4.89
$97.80K
James A Geraghty
17 Aug 2017
Director
Buy
10,000
$4.82
$48.20K
Allan Reine
16 Aug 2017
See Remarks
Buy
45,000
$4.79
$215.55K
Christopher P Kiritsy
21 Apr 2017
Director
Exercised, kept
5,000
$1.59
$7.95K

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 43
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 5,690,810
Sales filed before the plan box existed 8
History held since 8 Jul 2015